Trials / Completed
CompletedNCT00197782
The Immediate and Longterm Immune Responses of UK Infants and Young Children to a Booster Dose of Hib Vaccine
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Public Health England · Other Government
- Sex
- All
- Age
- 9 Months – 4 Years
- Healthy volunteers
- Accepted
Summary
To measure the magnitude and persistence of the antibody response to a booster dose of Hib conjugate vaccine given between 9 months and 4 years of age to UK children who had completed primary immunisation with 3 doses of Hib vaccine given at 2/3/4 months of age either as a combined D/T/wholecellpertussis/Hib or D/T/acellularpertussis/Hib vaccine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Hib conjugate vaccine |
Timeline
- Start date
- 2003-04-01
- Primary completion
- 2005-12-01
- Completion
- 2005-12-01
- First posted
- 2005-09-20
- Last updated
- 2018-08-24
Source: ClinicalTrials.gov record NCT00197782. Inclusion in this directory is not an endorsement.